Pasar al contenido principal

MECANISMOS DE REGULACION GENICA Y DE LA CROMATINA POR FACTORES DE TRANSCRIPCION MAESTROS

PID2023-147172NA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE SEVILLA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Integrative multi-omic analysis reveals a PAX8-driven gene network linking tumor stemness to therapy response in ovarian cancer

  • Santos-Pereira, José M.
  • Carnero, Amancio
  • Muñoz-Galván, Sandra
[Data availability] The public datasets in cell lines used in this study are available in the following databases: Gene Expression Omnibus with accession codes GSE227779 [55], GSE114964 [89], and GSE195677 [52]; Sequence Read Archive with accession codes PRJNA655844 [23] and PRJNA749469 [54]; and DNA Data Bank of Japan with accession code DRA010685 [53]. The patient datasets used in this study are available in the Gene Expression Omnibus with accession codes GSE18520, GSE204748, GSE38666, GSE40595, GSE63885, and GSE73168 [51–59, 63] and in the TCGA Research Network: https://www.cancer.gov/tcga., The transcription factor PAX8 is expressed in most ovarian tumors, being associated with increased tumorigenesis. Although recent studies have addressed the gene regulatory functions of PAX8 in ovarian cancer, an integrative analysis of multi-omic and patient data is required to identify the core regulatory network of PAX8 and its prognostic and therapeutic value. Here, we integrate PAX8 chromatin binding and accessibility data in ovarian cancer cells with transcriptomic and patients' data to gain insight into the core gene regulatory network orchestrated by PAX8 in ovarian tumors. Integration of differential chromatin accessibility, transcription factor binding, and gene expression upon PAX8 knockout provides a core regulatory network that explains most of the genes regulated by PAX8. We combine these target genes with patient expression data and find a PAX8 gene signature associated with tumor stemness, a property related to therapy resistance. Indeed, we show that the PAX8 gene signature predicts disease outcome and response to therapy in ovarian cancer patients. Finally, we validated experimentally our results from bioinformatic analyses, thus reassuring their robustness. Our findings uncover a PAX8 core network that represents a promising strategy for targeted antitumor therapies and open new pathways to fight against ovarian cancer resistance., SM-G is funded by grants from Fundación Ramón Areces (Proyecto Vida y Materia 2024); and grant PI-0121-2024 from Consejería de Salud y Consumo, Junta de Andalucía. AC is funded by grant PID2021-122629OB-I00 by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe” by the “European Union”; and by CIBER de Cáncer (CB16/12/00275). JMS-P is funded by “Emergia” Grant EMC21_00188 by Junta de Andalucía; grant PID2023-147172NA-I00 by MICIU/AEI/ 10.13039/501100011033 and by the “European Union”; and grant CNS2023-143945 by MICIU/AEI/10.13039/501100011033 and by “European Union NextGenerationEU/PRTR.”, Peer reviewed